NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis

Lancet Respir Med. 2013 Apr;1(2):102-3. doi: 10.1016/S2213-2600(13)70046-8. Epub 2013 Mar 27.
No abstract available

Publication types

  • News

MeSH terms

  • Administration, Inhalation
  • Anti-Bacterial Agents / administration & dosage
  • Clinical Trials as Topic
  • Colistin / administration & dosage
  • Colistin / analogs & derivatives*
  • Cystic Fibrosis* / diagnosis
  • Cystic Fibrosis* / drug therapy
  • Drug Monitoring / methods
  • Drug Therapy, Combination
  • Dry Powder Inhalers
  • Humans
  • Practice Guidelines as Topic
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / etiology
  • Respiratory Function Tests
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / etiology
  • State Medicine
  • Tobramycin / administration & dosage*
  • United Kingdom

Substances

  • Anti-Bacterial Agents
  • colistinmethanesulfonic acid
  • Tobramycin
  • Colistin